OUTSOURCE
Breast Cancer Markers Panel (Z306)
Also Known As:
CA 27.29 & CA 15.3 BREAST CANCER MARKERS PANEL
About This Test
Carcinoma breast is the most prevalent form of cancer in women. These tumors produce mucinous antigens encoded by human muc-1 gene. These antigens include CA 27.29 & CA 15.3. This panel is helpful in predicting early recurrence in women treated for Carcinoma breast.
Home Collection
✓ Available
Reports Available In
7 Days
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
No special preparation required
This panel is important for monitoring breast cancer treatment, detecting recurrence early, and guiding clinical decisions.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
